ClinicalTrials HQ

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

Active, not recruiting · NCT05502250 · Registry updated 2026-03-06
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete RemissionHemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22026-03-06NCT05502250

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Danish Lymphoma Group1
Stichting Hemato-Oncologie voor Volwassenen Nederland27

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BE-Bruxelles-STLUCBrusselsBelgium7
DK-Aarhus N-AUHAarhusDenmark2
DK-Copenhagen-RigshospitaletCopenhagenDenmark5
DK-Odense-OUHOdenseDenmark5
NL-Amersfoort-MEANDERMCAmersfoortNetherlands13
NL-Amsterdam-AMCAmsterdamNetherlands10
NL-Arnhem-RIJNSTATEArnhemNetherlands11
NL-Den Haag-HAGAThe HagueNetherlands13
NL-Eindhoven-MAXIMAMCEindhovenNetherlands11
NL-Goes-ADRZGoesNetherlands5
NL-Groningen-UMCGGroningenNetherlands17
NL-Hoofddorp-SPAARNEGASTHUISHoofddorpNetherlands7
NL-Leeuwarden-MCLLeeuwardenNetherlands10
NL-Maastricht-MUMCMaastrichtNetherlands13
NL-Rotterdam-ERASMUSMCRotterdamNetherlands14